Thioureidobutyronitrile Hydrochloride

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameThioureidobutyronitrile Hydrochloride
Drug Alias NameKevetrin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-3 activatorsTumor protein p53 stimulants
TargetsCaspase-3Tumor protein p53
Therapy Area/IndicationsSolid tumoursOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCellceutix Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSolid tumoursOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A